General Proximity

BiotechnologySeedSan Francisco, USgeneralproximity.bio

Latest round

Seed

Last raised

Dec 2024

Total raised

$16M

Investors

5

About General Proximity

Based in California, US, and founded in 2019 by Armand B. Cognetta (CEO), General Proximity operates as a biotechnology company that researches and develops induced-proximity medicines for dementia. General Proximity focuses on creating advanced proximity medicines using a discovery platform. The firm platform identifies proteins that play a key role in controlling biological processes by interacting with other proteins. General Proximity develops treatments that can activate, modify, or break down specific proteins to address difficult-to-treat medical targets. The frim work covers various health issues, including cancer, and collaborate with organizations like Johnson and Johnson and UCSF, serving clients mainly in North America and Europe.

Who invested in General Proximity

5 investors across 1 round

See all investors in General Proximity

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Seed

    Dec 18, 2024

    Amount

    $16M

    Investors

    Locked

Questions about General Proximity

Who invested in General Proximity?

General Proximity has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has General Proximity raised?

General Proximity has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did General Proximity last raise money?

General Proximity's most recent round on record is a Seed, in Dec 2024.

What does General Proximity do?

Based in California, US, and founded in 2019 by Armand B.

Where is General Proximity headquartered?

General Proximity is headquartered in San Francisco, US.

Which VCs invest in companies like General Proximity?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at General Proximity's stage. Their profiles are linked below.

Raising like General Proximity? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.